检验医学与临床
檢驗醫學與臨床
검험의학여림상
JOURNAL OF LABORATORY MEDICINE AND CLINICAL SCIENCES
2014年
6期
734-736
,共3页
郑君华%王永兵%顾天来%罗芸葆
鄭君華%王永兵%顧天來%囉蕓葆
정군화%왕영병%고천래%라예보
胃癌%淋巴结转移%hsa-miRNA-106a%miRNA基因芯片%实时荧光定量聚合酶联反应
胃癌%淋巴結轉移%hsa-miRNA-106a%miRNA基因芯片%實時熒光定量聚閤酶聯反應
위암%림파결전이%hsa-miRNA-106a%miRNA기인심편%실시형광정량취합매련반응
gastric cancer%lymph node metastasis%hsa-miRNA-106a%miRNA gene chip%real-time fluorescent quantitative polymerase chain reaction
目的:分析不同时期胃癌患者外周血中MicroRNA(miRNA)的表达差异,以寻找一种特异性高的肿瘤标记物。方法选取2010年5月至2012年12月上海浦东新区人民医院普外科住院治疗的80例胃癌患者,将其按照淋巴结转移数目分为N0组(无淋巴结转移)46例、N3组(淋巴结转移大于7枚)34例,并选取同一时期的体检健康者40例为健康对照组。取外周血进行基因芯片检测,并选择在 N0组与 N3组表达差异显著的 hsa-miR-106a ,采用实时荧光定量聚合酶联反应(qRT-PCR)扩大标本量进行检测。结果 qRT-PCR检测结果显示,N3组的外周血hsa-miR-106a表达水平较N0组及健康对照组明显上调,差异有统计学意义(P<0.05),但N0组与健康对照组外周血hsa-miR-106a表达水平差异无统计学意义(P>0.05)。hsa-miR-106a表达水平除了与胃癌淋巴结转移有关外(P<0.05),与患者性别、年龄、肿瘤大小、部位、组织学类型、肿瘤类型及分化程度都无关(P>0.05)。结论 hsa-miR-106a在有淋巴结转移的胃癌患者外周血中高表达,可作为胃癌筛查的重要肿瘤标记物。
目的:分析不同時期胃癌患者外週血中MicroRNA(miRNA)的錶達差異,以尋找一種特異性高的腫瘤標記物。方法選取2010年5月至2012年12月上海浦東新區人民醫院普外科住院治療的80例胃癌患者,將其按照淋巴結轉移數目分為N0組(無淋巴結轉移)46例、N3組(淋巴結轉移大于7枚)34例,併選取同一時期的體檢健康者40例為健康對照組。取外週血進行基因芯片檢測,併選擇在 N0組與 N3組錶達差異顯著的 hsa-miR-106a ,採用實時熒光定量聚閤酶聯反應(qRT-PCR)擴大標本量進行檢測。結果 qRT-PCR檢測結果顯示,N3組的外週血hsa-miR-106a錶達水平較N0組及健康對照組明顯上調,差異有統計學意義(P<0.05),但N0組與健康對照組外週血hsa-miR-106a錶達水平差異無統計學意義(P>0.05)。hsa-miR-106a錶達水平除瞭與胃癌淋巴結轉移有關外(P<0.05),與患者性彆、年齡、腫瘤大小、部位、組織學類型、腫瘤類型及分化程度都無關(P>0.05)。結論 hsa-miR-106a在有淋巴結轉移的胃癌患者外週血中高錶達,可作為胃癌篩查的重要腫瘤標記物。
목적:분석불동시기위암환자외주혈중MicroRNA(miRNA)적표체차이,이심조일충특이성고적종류표기물。방법선취2010년5월지2012년12월상해포동신구인민의원보외과주원치료적80례위암환자,장기안조림파결전이수목분위N0조(무림파결전이)46례、N3조(림파결전이대우7매)34례,병선취동일시기적체검건강자40례위건강대조조。취외주혈진행기인심편검측,병선택재 N0조여 N3조표체차이현저적 hsa-miR-106a ,채용실시형광정량취합매련반응(qRT-PCR)확대표본량진행검측。결과 qRT-PCR검측결과현시,N3조적외주혈hsa-miR-106a표체수평교N0조급건강대조조명현상조,차이유통계학의의(P<0.05),단N0조여건강대조조외주혈hsa-miR-106a표체수평차이무통계학의의(P>0.05)。hsa-miR-106a표체수평제료여위암림파결전이유관외(P<0.05),여환자성별、년령、종류대소、부위、조직학류형、종류류형급분화정도도무관(P>0.05)。결론 hsa-miR-106a재유림파결전이적위암환자외주혈중고표체,가작위위암사사적중요종류표기물。
Objective To analyze the expression differences of MicroRNA (miRNA) in peripheral blood of pa-tients with gastric carcinoma at different stages ,and to find tumor markers with high specificity .Methods A total of 80 patients with gastric cancer were divided into N 0 group (without lymph node metastasis ) of 46 cases and N3 group (with metastasis of more than 7 lymph nodes) of 34 cases .A total of 40 healthy subjects were enrolled as con-trol group .miRNA with significantly different expression level between N 0 and N3 group was identified by gene chip analysis ,and quantitative real -time fluorescent polymerase chain reaction (qRT-PCR) were performed for detection of expanded quantity of samples .Results hsa-miR-106a was identified as the miRNA with significantly different ex-pression level between N0 and N3 group ,with higher expression level in N3 group ,compared with N0 group and con-trol group (P<0 .05) ,but there was no statistical difference between N0 group and control group (P>0 .05) .Ex-pression level of hsa-miR-106a was correlated with lymph node metastasis of gastric cancer ,but not correlated with gender and age of patents and size ,location ,histological type and general type of tumor (P>0 .05) .Conclusion Ex-pression level of hsa-miR-106a in patients with lymph node metastasis of gastric cancer might be relatively high , which could be used as tumor marker for screening of gastric cancer .